<s id="wsj_0455.1"> 38
2 	 0 	 NP[nb]/N 	 1 	 Court The
2 	 1 	 N/N 	 1 	 Court Supreme
2 	 3 	 (S[dcl]\NP)/S[b] 	 1 	 Court let
4 	 3 	 (S[dcl]\NP)/S[b] 	 2 	 stand let
8 	 5 	 NP[nb]/N 	 1 	 court a
8 	 6 	 N/N 	 1 	 court New
8 	 7 	 N/N 	 1 	 court York
8 	 9 	 (NP[nb]/N)\NP 	 2 	 court 's
10 	 4 	 S[b]/NP 	 1 	 ruling stand
10 	 9 	 (NP[nb]/N)\NP 	 1 	 ruling 's
11 	 10 	 N/S[em] 	 1 	 that ruling
13 	 12 	 NP[nb]/N 	 1 	 manufacturers the
13 	 14 	 (NP\NP)/NP 	 1 	 manufacturers of
13 	 22 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 manufacturers must
13 	 23 	 ((S[b]\NP)/S[qem])/NP 	 1 	 manufacturers share <XB>
16 	 14 	 (NP\NP)/NP 	 2 	 drug of
16 	 15 	 NP[nb]/N 	 1 	 drug a
16 	 18 	 (S[pss]\NP)/(S[to]\NP) 	 1 	 drug used <XB>
16 	 20 	 (S[b]\NP)/NP 	 1 	 drug prevent <XB>
18 	 17 	 (S\NP)/(S\NP) 	 2 	 used once
19 	 18 	 (S[pss]\NP)/(S[to]\NP) 	 2 	 to used
20 	 19 	 (S[to]\NP)/(S[b]\NP) 	 2 	 prevent to
21 	 20 	 (S[b]\NP)/NP 	 2 	 miscarriages prevent
22 	 11 	 S[em]/S[dcl] 	 1 	 must that
23 	 22 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 share must
24 	 23 	 ((S[b]\NP)/S[qem])/NP 	 3 	 liability share
24 	 25 	 (NP\NP)/NP 	 1 	 liability for
26 	 25 	 (NP\NP)/NP 	 2 	 injuries for
28 	 25 	 (NP\NP)/NP 	 2 	 deaths for
29 	 23 	 ((S[b]\NP)/S[qem])/NP 	 2 	 when share
31 	 30 	 NP[nb]/N 	 1 	 maker the
31 	 32 	 (NP\NP)/NP 	 1 	 maker of
31 	 36 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 maker is
31 	 37 	 S[adj]\NP 	 1 	 maker unknown <XB>
35 	 32 	 (NP\NP)/NP 	 2 	 dose of
35 	 33 	 NP[nb]/N 	 1 	 dose an
35 	 34 	 N/N 	 1 	 dose individual
36 	 29 	 S[qem]/S[dcl] 	 1 	 is when
37 	 36 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 unknown is
<\s>
<s id="wsj_0455.2"> 25
2 	 0 	 NP[nb]/N 	 1 	 court The
2 	 1 	 N/N 	 1 	 court high
2 	 3 	 (NP[nb]/N)\NP 	 2 	 court 's
4 	 3 	 (NP[nb]/N)\NP 	 1 	 action 's
4 	 6 	 (S[ng]\NP)/(S[to]\NP) 	 1 	 action refusing <XB>
4 	 8 	 (S[b]\NP)/NP 	 1 	 action hear <XB>
4 	 15 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 action is
4 	 16 	 (S[adj]\NP)/(S[to]\NP) 	 1 	 action likely <XB>
7 	 6 	 (S[ng]\NP)/(S[to]\NP) 	 2 	 to refusing
8 	 7 	 (S[to]\NP)/(S[b]\NP) 	 2 	 hear to
9 	 8 	 (S[b]\NP)/NP 	 2 	 appeals hear
9 	 10 	 (NP\NP)/NP 	 1 	 appeals by
13 	 10 	 (NP\NP)/NP 	 2 	 companies by
13 	 11 	 N/N 	 1 	 companies several
13 	 12 	 N/N 	 1 	 companies drug
16 	 15 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 likely is
17 	 16 	 (S[adj]\NP)/(S[to]\NP) 	 2 	 to likely
18 	 17 	 (S[to]\NP)/(S[b]\NP) 	 2 	 have to
18 	 22 	 ((S\NP)\(S\NP))/NP 	 2 	 have at
21 	 18 	 (S[b]\NP)/NP 	 2 	 impact have
21 	 19 	 NP[nb]/N 	 1 	 impact a
21 	 20 	 N/N 	 1 	 impact significant
24 	 22 	 ((S\NP)\(S\NP))/NP 	 3 	 levels at
24 	 23 	 N/N 	 1 	 levels several
<\s>
<s id="wsj_0455.3"> 45
2 	 1 	 (N/N)/(N/N) 	 2 	 immediate most
3 	 0 	 NP[nb]/N 	 1 	 effect The
3 	 2 	 N/N 	 1 	 effect immediate
3 	 4 	 (S[dcl]\NP)/PP 	 1 	 effect is
5 	 4 	 (S[dcl]\NP)/PP 	 2 	 in is
7 	 5 	 PP/NP 	 1 	 York in
7 	 6 	 N/N 	 1 	 York New
7 	 9 	 (NP\NP)/S[dcl] 	 1 	 York where
11 	 10 	 N/N 	 1 	 manufacturers former
11 	 12 	 (NP\NP)/NP 	 1 	 manufacturers of
11 	 24 	 (S[dcl]\NP)/NP 	 1 	 manufacturers face
16 	 12 	 (NP\NP)/NP 	 2 	 DES of
16 	 13 	 NP[nb]/N 	 1 	 DES the
16 	 14 	 N/N 	 1 	 DES anti-miscarriage
16 	 15 	 N/N 	 1 	 DES drug
16 	 17 	 (NP\NP)/NP 	 1 	 DES --
22 	 17 	 (NP\NP)/NP 	 2 	 diethylstilbestrol --
22 	 18 	 NP[nb]/N 	 1 	 diethylstilbestrol the
22 	 19 	 N/N 	 1 	 diethylstilbestrol synthetic
22 	 20 	 N/N 	 1 	 diethylstilbestrol female
22 	 21 	 N/N 	 1 	 diethylstilbestrol hormone
24 	 9 	 (NP\NP)/S[dcl] 	 2 	 face where
24 	 32 	 ((S\NP)\(S\NP))/NP 	 2 	 face in
26 	 24 	 (S[dcl]\NP)/NP 	 2 	 prospect face
26 	 25 	 NP[nb]/N 	 1 	 prospect the
26 	 27 	 (NP\NP)/NP 	 1 	 prospect of
29 	 27 	 (NP\NP)/NP 	 2 	 liability of
29 	 28 	 N/N 	 1 	 liability shared
29 	 30 	 (NP\NP)/NP 	 1 	 liability for
31 	 30 	 (NP\NP)/NP 	 2 	 damages for
33 	 32 	 ((S\NP)\(S\NP))/NP 	 3 	 many in
33 	 34 	 (NP\NP)/NP 	 1 	 many of
36 	 37 	 ((N/N)\(N/N))/(N/N) 	 2 	 700 to
38 	 37 	 ((N/N)\(N/N))/(N/N) 	 3 	 1,000 to
40 	 34 	 (NP\NP)/NP 	 2 	 lawsuits of
40 	 35 	 NP[nb]/N 	 1 	 lawsuits the
40 	 36 	 N/N 	 1 	 lawsuits 700
40 	 39 	 N/N 	 1 	 lawsuits DES
40 	 41 	 S[ng]\NP 	 1 	 lawsuits pending <XB>
41 	 42 	 ((S\NP)\(S\NP))/NP 	 2 	 pending in
44 	 42 	 ((S\NP)\(S\NP))/NP 	 3 	 state in
44 	 43 	 NP[nb]/N 	 1 	 state that
<\s>
<s id="wsj_0455.4"> 20
1 	 0 	 NP[nb]/N 	 1 	 lawsuits The
1 	 2 	 (S[dcl]\NP)/PP 	 1 	 lawsuits stemmed
3 	 2 	 (S[dcl]\NP)/PP 	 2 	 from stemmed
5 	 3 	 PP/NP 	 1 	 development from
5 	 4 	 NP[nb]/N 	 1 	 development the
5 	 6 	 (NP\NP)/NP 	 1 	 development of
5 	 11 	 (NP\NP)/NP 	 1 	 development in
7 	 6 	 (NP\NP)/NP 	 2 	 cancer of
10 	 6 	 (NP\NP)/NP 	 2 	 problems of
10 	 9 	 N/N 	 1 	 problems other
13 	 11 	 (NP\NP)/NP 	 2 	 daughters in
13 	 12 	 NP[nb]/N 	 1 	 daughters the
13 	 14 	 (NP\NP)/NP 	 1 	 daughters of
15 	 14 	 (NP\NP)/NP 	 2 	 women of
15 	 16 	 (NP\NP)/(S[dcl]\NP) 	 1 	 women who
15 	 17 	 (S[dcl]\NP)/NP 	 1 	 women took <XB>
17 	 16 	 (NP\NP)/(S[dcl]\NP) 	 2 	 took who
19 	 17 	 (S[dcl]\NP)/NP 	 2 	 drug took
19 	 18 	 NP[nb]/N 	 1 	 drug the
<\s>
<s id="wsj_0455.5"> 36
3 	 0 	 (S/S)/NP 	 2 	 scale On
3 	 1 	 NP[nb]/N 	 1 	 scale a
3 	 2 	 N/N 	 1 	 scale broader
6 	 5 	 NP[nb]/N 	 1 	 ruling the
6 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 ruling could
6 	 8 	 ((S[b]\NP)/(S[to]\NP))/NP 	 1 	 ruling encourage <XB>
7 	 0 	 (S/S)/NP 	 1 	 could On
8 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 encourage could
10 	 9 	 N/N 	 1 	 states other
10 	 11 	 (NP[nb]/N)\NP 	 2 	 states '
12 	 8 	 ((S[b]\NP)/(S[to]\NP))/NP 	 3 	 courts encourage
12 	 11 	 (NP[nb]/N)\NP 	 1 	 courts '
12 	 14 	 (S[b]\NP)/NP 	 1 	 courts adopt <XB>
13 	 8 	 ((S[b]\NP)/(S[to]\NP))/NP 	 2 	 to encourage
14 	 13 	 (S[to]\NP)/(S[b]\NP) 	 2 	 adopt to
14 	 25 	 ((S\NP)\(S\NP))/NP 	 2 	 adopt in
14 	 29 	 ((S\NP)\(S\NP))/NP 	 2 	 adopt in <XU>
16 	 14 	 (S[b]\NP)/NP 	 2 	 logic adopt
16 	 15 	 NP[nb]/N 	 1 	 logic the
16 	 17 	 (NP\NP)/NP 	 1 	 logic of
21 	 17 	 (NP\NP)/NP 	 2 	 court of
21 	 18 	 NP[nb]/N 	 1 	 court the
21 	 19 	 N/N 	 1 	 court New
21 	 20 	 N/N 	 1 	 court York
24 	 23 	 (((S\NP)\(S\NP))/((S\NP)\(S\NP)))/(((S\NP)\(S\NP))/((S\NP)\(S\NP))) 	 4 	 only not
25 	 24 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 in only
25 	 35 	 ((S\NP)\(S\NP))\((S\NP)\(S\NP)) 	 3 	 in well
27 	 25 	 ((S\NP)\(S\NP))/NP 	 3 	 cases in
27 	 26 	 N/N 	 1 	 cases DES
29 	 24 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 in only
29 	 35 	 ((S\NP)\(S\NP))\((S\NP)\(S\NP)) 	 3 	 in well
32 	 29 	 ((S\NP)\(S\NP))/NP 	 3 	 lawsuits in
32 	 30 	 N/N 	 1 	 lawsuits other
32 	 31 	 N/N 	 1 	 lawsuits product-related
35 	 34 	 (((S\NP)\(S\NP))\((S\NP)\(S\NP)))/(((S\NP)\(S\NP))\((S\NP)\(S\NP))) 	 4 	 well as
<\s>
<s id="wsj_0455.6"> 34
3 	 1 	 (N/N)/(N/N) 	 2 	 Court New
3 	 2 	 (N/N)/(N/N) 	 2 	 Court York
3 	 4 	 ((N/N)\(N/N))/NP 	 2 	 Court of
5 	 4 	 ((N/N)\(N/N))/NP 	 3 	 Appeals of
6 	 0 	 NP[nb]/N 	 1 	 ruling The
6 	 3 	 N/N 	 1 	 ruling Court
6 	 7 	 (S[dcl]\NP)/NP 	 1 	 ruling parallels
10 	 7 	 (S[dcl]\NP)/NP 	 2 	 decision parallels
10 	 8 	 NP[nb]/N 	 1 	 decision a
10 	 9 	 N/N 	 1 	 decision 1980
10 	 11 	 (NP\NP)/NP 	 1 	 decision by
10 	 16 	 (S[ng]\NP)/NP 	 1 	 decision requiring <XB>
15 	 11 	 (NP\NP)/NP 	 2 	 Court by
15 	 12 	 NP[nb]/N 	 1 	 Court the
15 	 13 	 N/N 	 1 	 Court California
15 	 14 	 N/N 	 1 	 Court Supreme
16 	 23 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 requiring when
18 	 16 	 (S[ng]\NP)/NP 	 2 	 liability requiring
18 	 17 	 N/N 	 1 	 liability shared
18 	 19 	 (NP\NP)/NP 	 1 	 liability among
18 	 21 	 (NP\NP)/NP 	 1 	 liability for
20 	 19 	 (NP\NP)/NP 	 2 	 manufacturers among
22 	 21 	 (NP\NP)/NP 	 2 	 injuries for
24 	 25 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 it ca
24 	 28 	 (S[pss]\NP)/S[qem] 	 1 	 it determined <XB>
25 	 23 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 ca when
25 	 26 	 (S\NP)\(S\NP) 	 2 	 ca n't
27 	 25 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be ca
28 	 27 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 determined be
29 	 28 	 (S[pss]\NP)/S[qem] 	 2 	 which determined
30 	 29 	 (S[qem]/(S[dcl]\NP))/N 	 2 	 company which
30 	 31 	 (S[dcl]\NP)/PP 	 1 	 company is <XB>
31 	 29 	 (S[qem]/(S[dcl]\NP))/N 	 1 	 is which
32 	 31 	 (S[dcl]\NP)/PP 	 2 	 at is
33 	 32 	 PP/NP 	 1 	 fault at
<\s>
<s id="wsj_0455.7"> 32
1 	 0 	 N/N 	 1 	 Rheingold Paul
1 	 12 	 (S[dcl]\NP)/S[em] 	 1 	 Rheingold said
6 	 3 	 NP[nb]/N 	 1 	 lawyer a
6 	 4 	 N/N 	 1 	 lawyer New
6 	 5 	 N/N 	 1 	 lawyer York
6 	 7 	 (NP\NP)/(S[dcl]\NP) 	 1 	 lawyer who
6 	 8 	 (S[dcl]\NP)/NP 	 1 	 lawyer represents <XB>
6 	 12 	 (S[dcl]\NP)/S[em] 	 1 	 lawyer said
8 	 7 	 (NP\NP)/(S[dcl]\NP) 	 2 	 represents who
10 	 8 	 (S[dcl]\NP)/NP 	 2 	 victims represents
10 	 9 	 N/N 	 1 	 victims DES
13 	 12 	 (S[dcl]\NP)/S[em] 	 2 	 that said
18 	 14 	 (S/S)/NP 	 2 	 ruling before
18 	 15 	 NP[nb]/N 	 1 	 ruling the
18 	 16 	 N/N 	 1 	 ruling New
18 	 17 	 N/N 	 1 	 ruling York
22 	 20 	 NP/NP 	 1 	 states only
22 	 21 	 NP[nb]/N 	 1 	 states the
22 	 23 	 (NP\NP)/NP 	 1 	 states of
22 	 27 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 states had
22 	 28 	 (S[pt]\NP)/NP 	 1 	 states followed <XB>
24 	 23 	 (NP\NP)/NP 	 2 	 Washington of
26 	 23 	 (NP\NP)/NP 	 2 	 Wisconsin of
27 	 13 	 S[em]/S[dcl] 	 1 	 had that
27 	 14 	 (S/S)/NP 	 1 	 had before
28 	 27 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 followed had
31 	 28 	 (S[pt]\NP)/NP 	 2 	 decision followed
31 	 29 	 NP[nb]/N 	 1 	 decision the
31 	 30 	 N/N 	 1 	 decision California
<\s>
<s id="wsj_0455.8"> 16
1 	 0 	 (S/S)/S[em] 	 2 	 that Now
5 	 2 	 NP[nb]/N 	 1 	 decision the
5 	 3 	 N/N 	 1 	 decision New
5 	 4 	 N/N 	 1 	 decision York
5 	 6 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 decision has
5 	 8 	 (S[pss]\NP)/(S[adj]\NP) 	 1 	 decision left <XB>
5 	 9 	 S[adj]\NP 	 1 	 decision intact <XB>
6 	 1 	 S[em]/S[dcl] 	 1 	 has that
7 	 6 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been has
8 	 7 	 (S[pt]\NP)/(S[pss]\NP) 	 2 	 left been
9 	 8 	 (S[pss]\NP)/(S[adj]\NP) 	 2 	 intact left
12 	 11 	 N/N 	 1 	 states other
12 	 13 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 states may
12 	 14 	 (S[b]\NP)/NP 	 1 	 states follow <XB>
13 	 0 	 (S/S)/S[em] 	 1 	 may Now
14 	 13 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 follow may
15 	 14 	 (S[b]\NP)/NP 	 2 	 suit follow
<\s>
<s id="wsj_0455.9"> 27
4 	 3 	 N/N 	 1 	 York New
4 	 7 	 S[dcl]\NP 	 1 	 York go
6 	 7 	 S[dcl]\NP 	 1 	 California go
7 	 2 	 (S/S)/S[dcl] 	 2 	 go when
7 	 9 	 (S\NP)\(S\NP) 	 2 	 go way
9 	 8 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 way one
11 	 12 	 (S[dcl]\NP)/NP 	 1 	 it has
12 	 0 	 S/S 	 1 	 has Generally
12 	 2 	 (S/S)/S[dcl] 	 1 	 has when
12 	 24 	 (S[dcl]\S[dcl])/NP 	 1 	 has said
15 	 12 	 (S[dcl]\NP)/NP 	 2 	 influence has
15 	 13 	 NP[nb]/N 	 1 	 influence a
15 	 14 	 N/N 	 1 	 influence tremendous
15 	 16 	 (NP\NP)/NP 	 1 	 influence on
18 	 16 	 (NP\NP)/NP 	 2 	 states on
18 	 17 	 N/N 	 1 	 states other
22 	 16 	 (NP\NP)/NP 	 2 	 ones on
22 	 20 	 NP/NP 	 1 	 ones especially
22 	 21 	 N/N 	 1 	 ones small
26 	 24 	 (S[dcl]\S[dcl])/NP 	 2 	 Rheingold said
26 	 25 	 N/N 	 1 	 Rheingold Mr.
<\s>
<s id="wsj_0455.10"> 45
2 	 0 	 NP[nb]/N 	 1 	 court The
2 	 1 	 N/N 	 1 	 court high
2 	 3 	 (S[dcl]\NP)/(S[to]\NP) 	 1 	 court refused
2 	 5 	 (S[b]\NP)/NP 	 1 	 court hear <XB>
4 	 3 	 (S[dcl]\NP)/(S[to]\NP) 	 2 	 to refused
5 	 4 	 (S[to]\NP)/(S[b]\NP) 	 2 	 hear to
6 	 5 	 (S[b]\NP)/NP 	 2 	 appeals hear
6 	 7 	 (NP\NP)/NP 	 1 	 appeals by
10 	 7 	 (NP\NP)/NP 	 2 	 Co. by
10 	 8 	 N/N 	 1 	 Co. Rexall
10 	 9 	 N/N 	 1 	 Co. Drug
10 	 12 	 (NP\NP)/(S[dcl]\NP) 	 1 	 Co. which
10 	 13 	 (S[dcl]\NP)/PP 	 1 	 Co. went <XB>
10 	 20 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 Co. was <XU>
10 	 21 	 S[pss]\NP 	 1 	 Co. taken <XU>
13 	 12 	 (NP\NP)/(S[dcl]\NP) 	 2 	 went which
13 	 17 	 ((S\NP)\(S\NP))/NP 	 2 	 went in
15 	 13 	 (S[dcl]\NP)/PP 	 2 	 of went
15 	 14 	 PP/PP 	 1 	 of out
16 	 15 	 PP/NP 	 1 	 business of
18 	 17 	 ((S\NP)\(S\NP))/NP 	 3 	 1987 in
20 	 12 	 (NP\NP)/(S[dcl]\NP) 	 2 	 was which
21 	 20 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 taken was
21 	 22 	 (S\NP)\(S\NP) 	 2 	 taken over
21 	 23 	 ((S\NP)\(S\NP))/NP 	 2 	 taken by
26 	 23 	 ((S\NP)\(S\NP))/NP 	 3 	 Trust by
26 	 24 	 N/N 	 1 	 Trust RXDC
26 	 25 	 N/N 	 1 	 Trust Liquidating
32 	 23 	 ((S\NP)\(S\NP))/NP 	 3 	 Inc. by
32 	 28 	 N/N 	 1 	 Inc. E.R.
32 	 29 	 N/N 	 1 	 Inc. Squibb
32 	 30 	 N/N 	 1 	 Inc. &
32 	 31 	 N/N 	 1 	 Inc. Sons
35 	 23 	 ((S\NP)\(S\NP))/NP 	 3 	 unit by
35 	 34 	 NP[nb]/N 	 1 	 unit a
35 	 36 	 (NP\NP)/NP 	 1 	 unit of
38 	 36 	 (NP\NP)/NP 	 2 	 Corp. of
38 	 37 	 N/N 	 1 	 Corp. Squibb
44 	 23 	 ((S\NP)\(S\NP))/NP 	 3 	 Co by
44 	 41 	 N/N 	 1 	 Co Eli
44 	 42 	 N/N 	 1 	 Co Lilly
44 	 43 	 N/N 	 1 	 Co &
<\s>
<s id="wsj_0455.11"> 26
1 	 0 	 NP[nb]/N 	 1 	 appeals The
1 	 2 	 (S[dcl]\NP)/NP 	 1 	 appeals involved
3 	 2 	 (S[dcl]\NP)/NP 	 2 	 DES involved
3 	 5 	 (NP\NP)/(S[dcl]\NP) 	 1 	 DES which
3 	 6 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 DES was <XB>
3 	 7 	 (S[pss]\NP)/PP 	 1 	 DES approved <XB>
6 	 5 	 (NP\NP)/(S[dcl]\NP) 	 2 	 was which
7 	 6 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 approved was
7 	 8 	 ((S\NP)\(S\NP))/NP 	 2 	 approved by
10 	 8 	 ((S\NP)\(S\NP))/NP 	 3 	 Food by
10 	 9 	 NP[nb]/N 	 1 	 Food the
13 	 8 	 ((S\NP)\(S\NP))/NP 	 3 	 Administration by
13 	 9 	 NP[nb]/N 	 1 	 Administration the
13 	 12 	 N/N 	 1 	 Administration Drug
14 	 7 	 (S[pss]\NP)/PP 	 2 	 for approved
15 	 14 	 PP/NP 	 1 	 use for
15 	 19 	 (NP\NP)/NP 	 1 	 use until
18 	 16 	 ((NP\NP)/(NP\NP))/NP 	 3 	 1940s from
18 	 17 	 NP[nb]/N 	 1 	 1940s the
19 	 16 	 ((NP\NP)/(NP\NP))/NP 	 2 	 until from
20 	 19 	 (NP\NP)/NP 	 2 	 1971 until
22 	 21 	 (S[to]\NP)/(S[b]\NP) 	 2 	 prevent to
22 	 24 	 ((S\NP)\(S\NP))/NP 	 2 	 prevent during
23 	 22 	 (S[b]\NP)/NP 	 2 	 miscarriages prevent
25 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 pregnancy during
<\s>
<s id="wsj_0455.12"> 27
1 	 0 	 (S/S)/NP 	 2 	 1971 In
4 	 3 	 NP[nb]/N 	 1 	 FDA the
4 	 5 	 (S[dcl]\NP)/NP 	 1 	 FDA banned
5 	 0 	 (S/S)/NP 	 1 	 banned In
5 	 10 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 banned after
7 	 5 	 (S[dcl]\NP)/NP 	 2 	 use banned
7 	 6 	 NP[nb]/N 	 1 	 use the
7 	 8 	 (NP\NP)/NP 	 1 	 use of
9 	 8 	 (NP\NP)/NP 	 2 	 DES of
11 	 12 	 ((S[dcl]\NP)/PP)/NP 	 1 	 studies linked
12 	 10 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 linked after
13 	 12 	 ((S[dcl]\NP)/PP)/NP 	 3 	 it linked
14 	 12 	 ((S[dcl]\NP)/PP)/NP 	 2 	 to linked
15 	 14 	 PP/NP 	 1 	 cancer to
15 	 19 	 (NP\NP)/NP 	 1 	 cancer in
18 	 14 	 PP/NP 	 1 	 problems to
18 	 17 	 N/N 	 1 	 problems other
18 	 19 	 (NP\NP)/NP 	 1 	 problems in
20 	 19 	 (NP\NP)/NP 	 2 	 daughters in
20 	 21 	 (NP\NP)/NP 	 1 	 daughters of
22 	 21 	 (NP\NP)/NP 	 2 	 women of
22 	 23 	 (NP\NP)/(S[dcl]\NP) 	 1 	 women who
22 	 24 	 (S[dcl]\NP)/NP 	 1 	 women took <XB>
24 	 23 	 (NP\NP)/(S[dcl]\NP) 	 2 	 took who
26 	 24 	 (S[dcl]\NP)/NP 	 2 	 drug took
26 	 25 	 NP[nb]/N 	 1 	 drug the
<\s>
<s id="wsj_0455.13"> 17
0 	 1 	 (NP\NP)/NP 	 1 	 Lawsuits over
0 	 7 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 Lawsuits have
0 	 8 	 (S[pt]\NP)/NP 	 1 	 Lawsuits flooded <XB>
3 	 1 	 (NP\NP)/NP 	 2 	 harm over
3 	 2 	 NP[nb]/N 	 1 	 harm the
3 	 4 	 S[pss]\NP 	 1 	 harm caused <XB>
4 	 5 	 ((S\NP)\(S\NP))/NP 	 2 	 caused by
6 	 5 	 ((S\NP)\(S\NP))/NP 	 3 	 DES by
8 	 7 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 flooded have
8 	 13 	 ((S\NP)\(S\NP))/NP 	 2 	 flooded in
12 	 8 	 (S[pt]\NP)/NP 	 2 	 courts flooded
12 	 9 	 N/N 	 1 	 courts federal <XU>
12 	 11 	 N/N 	 1 	 courts state
16 	 13 	 ((S\NP)\(S\NP))/NP 	 3 	 decade in
16 	 14 	 NP[nb]/N 	 1 	 decade the
16 	 15 	 N/N 	 1 	 decade past
<\s>
<s id="wsj_0455.14"> 45
2 	 0 	 (S/S)/NP 	 2 	 cases In
2 	 1 	 N/N 	 1 	 cases many
5 	 4 	 NP[nb]/N 	 1 	 lawsuit the
5 	 6 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 lawsuit was
5 	 7 	 S[pss]\NP 	 1 	 lawsuit filed <XB>
6 	 0 	 (S/S)/NP 	 1 	 was In
6 	 14 	 (S\S)/S[dcl] 	 1 	 was --
7 	 6 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 filed was
7 	 9 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 filed after
9 	 8 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 after long
11 	 10 	 NP[nb]/N 	 1 	 drug the
11 	 12 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 drug was
11 	 13 	 S[pss]\NP 	 1 	 drug used <XB>
12 	 9 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 was after
13 	 12 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 used was
16 	 15 	 NP[nb]/N 	 1 	 cancer the
16 	 17 	 (NP\NP)/NP 	 1 	 cancer in
16 	 20 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 cancer was
16 	 23 	 S[pss]\NP 	 1 	 cancer detected <XB>
19 	 17 	 (NP\NP)/NP 	 2 	 daughters in
19 	 18 	 NP[nb]/N 	 1 	 daughters the
20 	 14 	 (S\S)/S[dcl] 	 2 	 was --
20 	 21 	 (S\NP)\(S\NP) 	 2 	 was typically
20 	 22 	 (S\NP)\(S\NP) 	 2 	 was not
23 	 20 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 detected was
23 	 24 	 ((S\NP)\(S\NP))/NP 	 2 	 detected for
25 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 years for
28 	 29 	 (S[dcl]\NP[thr])/NP 	 1 	 there is
29 	 0 	 (S/S)/NP 	 1 	 is In
31 	 29 	 (S[dcl]\NP[thr])/NP 	 2 	 way is
31 	 30 	 NP[nb]/N 	 1 	 way no
33 	 32 	 (S[to]\NP)/(S[b]\NP) 	 2 	 prove to
34 	 33 	 (S[b]\NP)/S[qem] 	 2 	 which prove
34 	 35 	 (S\S)/NP 	 1 	 which of
37 	 35 	 (S\S)/NP 	 2 	 companies of
37 	 36 	 N/N 	 1 	 companies several
38 	 34 	 S[qem]/(S[dcl]\NP) 	 1 	 manufactured which
40 	 38 	 (S[dcl]\NP)/NP 	 2 	 doses manufactured
40 	 39 	 NP[nb]/N 	 1 	 doses the
40 	 41 	 S[pss]\NP 	 1 	 doses consumed <XB>
41 	 42 	 ((S\NP)\(S\NP))/NP 	 2 	 consumed by
44 	 42 	 ((S\NP)\(S\NP))/NP 	 3 	 women by
44 	 43 	 N/N 	 1 	 women certain
<\s>
<s id="wsj_0455.15"> 26
3 	 0 	 (S/S)/NP 	 2 	 theories Under
3 	 1 	 N/N 	 1 	 theories traditional
3 	 2 	 N/N 	 1 	 theories legal
5 	 7 	 (S[b]\NP)/S[qem] 	 1 	 inability prove <XB>
5 	 19 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 inability would
5 	 20 	 (S[b]\NP)/PP 	 1 	 inability lead <XB>
7 	 6 	 (S[to]\NP)/(S[b]\NP) 	 2 	 prove to
8 	 7 	 (S[b]\NP)/S[qem] 	 2 	 which prove
9 	 8 	 (S[qem]/(S[dcl]\NP))/N 	 2 	 company which
9 	 10 	 (S[dcl]\NP)/NP 	 1 	 company manufactured <XB>
10 	 8 	 (S[qem]/(S[dcl]\NP))/N 	 1 	 manufactured which
12 	 10 	 (S[dcl]\NP)/NP 	 2 	 drug manufactured
12 	 11 	 NP[nb]/N 	 1 	 drug a
12 	 13 	 (NP\NP)/(S[dcl]\NP) 	 1 	 drug that
12 	 14 	 (S[dcl]\NP)/NP 	 1 	 drug caused <XB>
14 	 13 	 (NP\NP)/(S[dcl]\NP) 	 2 	 caused that
16 	 14 	 (S[dcl]\NP)/NP 	 2 	 injury caused
16 	 15 	 NP[nb]/N 	 1 	 injury an
18 	 14 	 (S[dcl]\NP)/NP 	 2 	 death caused
18 	 15 	 NP[nb]/N 	 1 	 death an
19 	 0 	 (S/S)/NP 	 1 	 would Under
20 	 19 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 lead would
21 	 20 	 (S[b]\NP)/PP 	 2 	 to lead
23 	 21 	 (PP/(S[ng]\NP))/NP 	 2 	 lawsuit to
23 	 22 	 NP[nb]/N 	 1 	 lawsuit the
23 	 24 	 (S[ng]\NP)/(S[pss]\NP) 	 1 	 lawsuit being <XB>
23 	 25 	 S[pss]\NP 	 1 	 lawsuit dismissed <XB>
24 	 21 	 (PP/(S[ng]\NP))/NP 	 1 	 being to
25 	 24 	 (S[ng]\NP)/(S[pss]\NP) 	 2 	 dismissed being
<\s>
<s id="wsj_0455.16"> 33
5 	 1 	 (S/S)/NP 	 2 	 April in
5 	 2 	 NP[nb]/N 	 1 	 April its
5 	 3 	 N/N 	 1 	 April ruling
5 	 4 	 N/N 	 1 	 April last
10 	 7 	 NP[nb]/N 	 1 	 court the
10 	 8 	 N/N 	 1 	 court New
10 	 9 	 N/N 	 1 	 court York
10 	 11 	 (S[dcl]\NP)/S[em] 	 1 	 court said
11 	 0 	 S/S 	 1 	 said But
11 	 1 	 (S/S)/NP 	 1 	 said in
12 	 11 	 (S[dcl]\NP)/S[em] 	 2 	 that said
14 	 13 	 NP[nb]/N 	 1 	 producers all
14 	 15 	 (NP\NP)/NP 	 1 	 producers of
14 	 19 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 producers should
14 	 20 	 (S[b]\NP)/NP 	 1 	 producers share <XB>
18 	 15 	 (NP\NP)/NP 	 2 	 drug of
18 	 16 	 NP[nb]/N 	 1 	 drug the
18 	 17 	 N/N 	 1 	 drug anti-miscarriage
19 	 12 	 S[em]/S[dcl] 	 1 	 should that
20 	 19 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 share should
20 	 22 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 share when
21 	 20 	 (S[b]\NP)/NP 	 2 	 liability share
24 	 23 	 NP[nb]/N 	 1 	 manufacturer the
24 	 25 	 (NP\NP)/NP 	 1 	 manufacturer of
24 	 29 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 manufacturer ca
24 	 32 	 S[pss]\NP 	 1 	 manufacturer determined <XB>
28 	 25 	 (NP\NP)/NP 	 2 	 dose of
28 	 26 	 NP[nb]/N 	 1 	 dose a
28 	 27 	 N/N 	 1 	 dose specific
29 	 22 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 ca when
29 	 30 	 (S\NP)\(S\NP) 	 2 	 ca n't
31 	 29 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be ca
32 	 31 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 determined be
<\s>
<s id="wsj_0455.17"> 17
1 	 0 	 NP[nb]/N 	 1 	 company Each
1 	 2 	 (NP[nb]/N)\NP 	 2 	 company 's
3 	 2 	 (NP[nb]/N)\NP 	 1 	 share 's
3 	 4 	 (NP\NP)/NP 	 1 	 share of
3 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 share would
3 	 8 	 (S[pss]\NP)/PP 	 1 	 share based <XB>
5 	 4 	 (NP\NP)/NP 	 2 	 liability of
7 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be would
8 	 7 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 based be
9 	 8 	 (S[pss]\NP)/PP 	 2 	 on based
11 	 9 	 PP/NP 	 1 	 share on
11 	 10 	 NP[nb]/N 	 1 	 share their
11 	 12 	 (NP\NP)/NP 	 1 	 share of
16 	 12 	 (NP\NP)/NP 	 2 	 market of
16 	 13 	 NP[nb]/N 	 1 	 market the
16 	 14 	 N/N 	 1 	 market national
16 	 15 	 N/N 	 1 	 market DES
<\s>
<s id="wsj_0455.18"> 26
3 	 0 	 NP[nb]/N 	 1 	 court The
3 	 1 	 N/N 	 1 	 court New
3 	 2 	 N/N 	 1 	 court York
3 	 5 	 (S[dcl]\NP)/NP 	 1 	 court upheld
5 	 4 	 (S\NP)/(S\NP) 	 2 	 upheld also
8 	 5 	 (S[dcl]\NP)/NP 	 2 	 law upheld
8 	 6 	 NP[nb]/N 	 1 	 law a
8 	 7 	 N/N 	 1 	 law state
8 	 10 	 S[pss]\NP 	 1 	 law passed <XB>
8 	 14 	 (S[ng]\NP)/NP 	 1 	 law extending <XB>
10 	 11 	 ((S\NP)\(S\NP))/NP 	 2 	 passed in
12 	 11 	 ((S\NP)\(S\NP))/NP 	 3 	 1986 in
14 	 15 	 ((S\NP)\(S\NP))/NP 	 2 	 extending for
17 	 15 	 ((S\NP)\(S\NP))/NP 	 3 	 year for
17 	 16 	 N/N 	 1 	 year one
19 	 14 	 (S[ng]\NP)/NP 	 2 	 statute extending
19 	 18 	 NP[nb]/N 	 1 	 statute the
19 	 20 	 (NP\NP)/NP 	 1 	 statute of
19 	 22 	 (NP\NP)/NP 	 1 	 statute on
21 	 20 	 (NP\NP)/NP 	 2 	 limitations of
25 	 22 	 (NP\NP)/NP 	 2 	 lawsuits on
25 	 23 	 N/N 	 1 	 lawsuits filing
25 	 24 	 N/N 	 1 	 lawsuits DES
<\s>
<s id="wsj_0455.19"> 23
1 	 0 	 NP[nb]/N 	 1 	 effect The
1 	 2 	 (S[dcl]\NP)/S[em] 	 1 	 effect is
3 	 2 	 (S[dcl]\NP)/S[em] 	 2 	 that is
4 	 5 	 (NP\NP)/(S[dcl]\NP) 	 1 	 lawsuits that
4 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 lawsuits might <XB>
4 	 9 	 S[pss]\NP 	 1 	 lawsuits barred <XB>
4 	 16 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 lawsuits could
4 	 17 	 S[b]\NP 	 1 	 lawsuits proceed <XB>
6 	 5 	 (NP\NP)/(S[dcl]\NP) 	 2 	 might that
7 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 have might
8 	 7 	 (S[b]\NP)/(S[pt]\NP) 	 2 	 been have
9 	 8 	 (S[pt]\NP)/(S[pss]\NP) 	 2 	 barred been
9 	 10 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 barred because
11 	 12 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 they were
11 	 13 	 S[pss]\NP 	 1 	 they filed <XB>
12 	 10 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 were because
13 	 12 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 filed were
13 	 15 	 (S\NP)\(S\NP) 	 2 	 filed late
15 	 14 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 late too
16 	 3 	 S[em]/S[dcl] 	 1 	 could that
17 	 16 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 proceed could
17 	 18 	 ((S\NP)\(S\NP))/PP 	 2 	 proceed because
19 	 18 	 ((S\NP)\(S\NP))/PP 	 3 	 of because
22 	 19 	 PP/NP 	 1 	 extension of
22 	 20 	 NP[nb]/N 	 1 	 extension the
22 	 21 	 N/N 	 1 	 extension one-year
<\s>
<s id="wsj_0455.20"> 22
3 	 1 	 N/N 	 1 	 Co. Rexall
3 	 2 	 N/N 	 1 	 Co. Drug
3 	 4 	 (NP\NP)/NP 	 1 	 Co. vs.
5 	 4 	 (NP\NP)/NP 	 2 	 Tigue vs.
11 	 7 	 N/N 	 1 	 Inc. E.R.
11 	 8 	 N/N 	 1 	 Inc. Squibb
11 	 9 	 N/N 	 1 	 Inc. &
11 	 10 	 N/N 	 1 	 Inc. Sons
11 	 12 	 (NP\NP)/NP 	 1 	 Inc. vs.
13 	 12 	 (NP\NP)/NP 	 2 	 Hymowitz vs.
19 	 16 	 N/N 	 1 	 Co. Eli
19 	 17 	 N/N 	 1 	 Co. Lilly
19 	 18 	 N/N 	 1 	 Co. &
19 	 20 	 (NP\NP)/NP 	 1 	 Co. vs.
21 	 20 	 (NP\NP)/NP 	 2 	 Hymowitz vs.
<\s>
<s id="wsj_0455.21"> 1
1 	 0 	 N/N 	 1 	 Contractors Government
<\s>
<s id="wsj_0455.22"> 33
2 	 0 	 NP[nb]/N 	 1 	 court The
2 	 1 	 N/N 	 1 	 court high
2 	 4 	 ((S[ng]\NP)/NP)/(S[adj]\NP) 	 1 	 court leaving <XB>
2 	 17 	 (S[dcl]\NP)/(S[to]\NP) 	 1 	 court declined
2 	 19 	 (S[b]\NP)/NP 	 1 	 court resolve <XB>
5 	 4 	 ((S[ng]\NP)/NP)/(S[adj]\NP) 	 3 	 intact leaving
9 	 7 	 (N/N)/N[num] 	 2 	 million $
9 	 8 	 N/N 	 1 	 million 4.25
11 	 4 	 ((S[ng]\NP)/NP)/(S[adj]\NP) 	 2 	 award leaving
11 	 5 	 S[adj]\NP 	 1 	 award intact <XB>
11 	 6 	 NP[nb]/N 	 1 	 award a
11 	 7 	 (N/N)/N[num] 	 1 	 award $
11 	 10 	 N/N 	 1 	 award damage
11 	 12 	 (NP\NP)/NP 	 1 	 award against
15 	 12 	 (NP\NP)/NP 	 2 	 Corp. against
15 	 13 	 N/N 	 1 	 Corp. General
15 	 14 	 N/N 	 1 	 Corp. Dynamics
18 	 17 	 (S[dcl]\NP)/(S[to]\NP) 	 2 	 to declined
19 	 18 	 (S[to]\NP)/(S[b]\NP) 	 2 	 resolve to
20 	 19 	 (S[b]\NP)/NP 	 2 	 questions resolve
20 	 21 	 (NP\NP)/NP 	 1 	 questions about
24 	 21 	 (NP\NP)/NP 	 2 	 defense about
24 	 22 	 NP[nb]/N 	 1 	 defense a
24 	 23 	 N/N 	 1 	 defense legal
24 	 25 	 (NP\NP)/NP 	 1 	 defense against
24 	 29 	 S[pss]\NP 	 1 	 defense used <XB>
27 	 25 	 (NP\NP)/NP 	 2 	 lawsuits against
27 	 26 	 N/N 	 1 	 lawsuits civil
29 	 28 	 (S\NP)/(S\NP) 	 2 	 used often
29 	 30 	 ((S\NP)\(S\NP))/NP 	 2 	 used by
32 	 30 	 ((S\NP)\(S\NP))/NP 	 3 	 contractors by
32 	 31 	 N/N 	 1 	 contractors government
<\s>
<s id="wsj_0455.23"> 37
1 	 0 	 (S/S)/(S/S) 	 2 	 year Last
5 	 3 	 NP[nb]/N 	 1 	 Court the
5 	 4 	 N/N 	 1 	 Court Supreme
5 	 6 	 (S[dcl]\NP)/S[qem] 	 1 	 Court defined
6 	 1 	 S/S 	 1 	 defined year
7 	 6 	 (S[dcl]\NP)/S[qem] 	 2 	 when defined
8 	 11 	 (NP\NP)/NP 	 1 	 companies as
8 	 15 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 companies may
8 	 16 	 ((S[b]\NP)/PP)/NP 	 1 	 companies defend <XB>
8 	 25 	 (S[ng]\NP)/S[em] 	 1 	 companies asserting <XB>
11 	 10 	 (NP\NP)/(NP\NP) 	 2 	 as such
13 	 11 	 (NP\NP)/NP 	 2 	 contractors as
13 	 12 	 N/N 	 1 	 contractors military
15 	 7 	 S[qem]/S[dcl] 	 1 	 may when
16 	 15 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 defend may
16 	 24 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 2 	 defend by
17 	 16 	 ((S[b]\NP)/PP)/NP 	 3 	 themselves defend
18 	 16 	 ((S[b]\NP)/PP)/NP 	 2 	 against defend
19 	 18 	 PP/NP 	 1 	 lawsuits against
19 	 20 	 (NP\NP)/NP 	 1 	 lawsuits for
21 	 20 	 (NP\NP)/NP 	 2 	 deaths for
23 	 20 	 (NP\NP)/NP 	 2 	 injuries for
25 	 24 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 asserting by
26 	 25 	 (S[ng]\NP)/S[em] 	 2 	 that asserting
27 	 28 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 they were
27 	 30 	 (S[ng]\NP)/NP 	 1 	 they following <XB>
28 	 26 	 S[em]/S[dcl] 	 1 	 were that
30 	 28 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 following were
30 	 29 	 (S\NP)/(S\NP) 	 2 	 following simply
31 	 30 	 (S[ng]\NP)/NP 	 2 	 specifications following
31 	 32 	 (NP\NP)/NP 	 1 	 specifications of
36 	 32 	 (NP\NP)/NP 	 2 	 contract of
36 	 33 	 NP[nb]/N 	 1 	 contract a
36 	 34 	 N/N 	 1 	 contract federal
36 	 35 	 N/N 	 1 	 contract government
<\s>
<s id="wsj_0455.24"> 41
2 	 0 	 (S/S)/NP 	 2 	 decision In
2 	 1 	 NP[nb]/N 	 1 	 decision that
6 	 4 	 NP[nb]/N 	 1 	 court the
6 	 5 	 N/N 	 1 	 court high
6 	 7 	 (S[dcl]\NP)/S[dcl] 	 1 	 court said
7 	 0 	 (S/S)/NP 	 1 	 said In
9 	 8 	 NP[nb]/N 	 1 	 company a
9 	 10 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 company must
9 	 11 	 (S[b]\NP)/S[em] 	 1 	 company prove <XB>
10 	 7 	 (S[dcl]\NP)/S[dcl] 	 2 	 must said
11 	 10 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 prove must
12 	 11 	 (S[b]\NP)/S[em] 	 2 	 that prove
14 	 13 	 NP[nb]/N 	 1 	 government the
14 	 15 	 (S[dcl]\NP)/NP 	 1 	 government approved
15 	 12 	 S[em]/S[dcl] 	 1 	 approved that
17 	 15 	 (S[dcl]\NP)/NP 	 2 	 specifications approved
17 	 16 	 N/N 	 1 	 specifications precise
17 	 18 	 (NP\NP)/NP 	 1 	 specifications for
20 	 18 	 (NP\NP)/NP 	 2 	 contract for
20 	 19 	 NP[nb]/N 	 1 	 contract the
22 	 11 	 (S[b]\NP)/S[em] 	 2 	 that prove
24 	 23 	 NP[nb]/N 	 1 	 specifications those
24 	 25 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 specifications were
24 	 26 	 S[pss]\NP 	 1 	 specifications met <XB>
25 	 22 	 S[em]/S[dcl] 	 1 	 were that
26 	 25 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 met were
28 	 11 	 (S[b]\NP)/S[em] 	 2 	 that prove
30 	 29 	 NP[nb]/N 	 1 	 government the
30 	 31 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 government was
30 	 32 	 (S[pss]\NP)/PP 	 1 	 government warned <XB>
31 	 28 	 S[em]/S[dcl] 	 1 	 was that
32 	 31 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 warned was
33 	 32 	 (S[pss]\NP)/PP 	 2 	 of warned
35 	 33 	 PP/NP 	 1 	 dangers of
35 	 34 	 NP[nb]/N 	 1 	 dangers any
35 	 36 	 (NP\NP)/NP 	 1 	 dangers in
37 	 36 	 (NP\NP)/NP 	 2 	 use in
37 	 38 	 (NP\NP)/NP 	 1 	 use of
40 	 38 	 (NP\NP)/NP 	 2 	 equipment of
40 	 39 	 NP[nb]/N 	 1 	 equipment the
<\s>
<s id="wsj_0455.25"> 29
2 	 1 	 (S/S)/(S/S) 	 2 	 February last
7 	 4 	 NP[nb]/N 	 1 	 court a
7 	 5 	 N/N 	 1 	 court federal
7 	 6 	 N/N 	 1 	 court appeals
7 	 8 	 (NP\NP)/NP 	 1 	 court in
7 	 11 	 (S[dcl]\NP)/NP 	 1 	 court upheld
7 	 19 	 (S[ng]\NP)/NP 	 1 	 court rejecting <XB>
10 	 8 	 (NP\NP)/NP 	 2 	 Orleans in
10 	 9 	 N/N 	 1 	 Orleans New
11 	 0 	 S/S 	 1 	 upheld But
11 	 2 	 S/S 	 1 	 upheld February
14 	 11 	 (S[dcl]\NP)/NP 	 2 	 award upheld
14 	 12 	 NP[nb]/N 	 1 	 award a
14 	 13 	 N/N 	 1 	 award damage
14 	 15 	 (NP\NP)/NP 	 1 	 award against
17 	 15 	 (NP\NP)/NP 	 2 	 Dynamics against
17 	 16 	 N/N 	 1 	 Dynamics General
21 	 20 	 NP[nb]/N 	 1 	 company the
21 	 22 	 (NP[nb]/N)\NP 	 2 	 company 's
23 	 19 	 (S[ng]\NP)/NP 	 2 	 use rejecting
23 	 22 	 (NP[nb]/N)\NP 	 1 	 use 's
23 	 24 	 (NP\NP)/NP 	 1 	 use of
28 	 24 	 (NP\NP)/NP 	 2 	 defense of
28 	 25 	 NP[nb]/N 	 1 	 defense the
28 	 26 	 N/N 	 1 	 defense government
28 	 27 	 N/N 	 1 	 defense contractor
<\s>
<s id="wsj_0455.26"> 38
2 	 0 	 NP[nb]/N 	 1 	 court The
2 	 1 	 N/N 	 1 	 court appeals
2 	 3 	 (S[dcl]\NP)/S[dcl] 	 1 	 court said
5 	 4 	 NP[nb]/N 	 1 	 defense the
5 	 6 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 defense is
5 	 7 	 S[adj]\NP 	 1 	 defense valid <XB>
6 	 3 	 (S[dcl]\NP)/S[dcl] 	 2 	 is said
6 	 9 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 is if
7 	 6 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 valid is
9 	 8 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 if only
11 	 10 	 N/N 	 1 	 officials federal
11 	 12 	 (S[dcl]\NP)/NP 	 1 	 officials did
11 	 24 	 (S[dcl]\NP)/PP 	 1 	 officials engaged <XU>
12 	 9 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 did if
13 	 12 	 (S[dcl]\NP)/NP 	 2 	 more did
13 	 14 	 (NP\NP)/(S[dcl]\NP) 	 1 	 more than
13 	 15 	 (S[dcl]\NP)/NP 	 1 	 more rubber <XB>
15 	 14 	 (NP\NP)/(S[dcl]\NP) 	 2 	 rubber than
15 	 16 	 (S\NP)\(S\NP) 	 2 	 rubber stamp
18 	 17 	 NP[nb]/N 	 1 	 company a
18 	 19 	 (NP[nb]/N)\NP 	 2 	 company 's
20 	 15 	 (S[dcl]\NP)/NP 	 2 	 design rubber
20 	 19 	 (NP[nb]/N)\NP 	 1 	 design 's
22 	 15 	 (S[dcl]\NP)/NP 	 2 	 plans rubber
22 	 19 	 (NP[nb]/N)\NP 	 1 	 plans 's
24 	 9 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 engaged if
25 	 24 	 (S[dcl]\NP)/PP 	 2 	 in engaged
28 	 25 	 PP/NP 	 1 	 review in
28 	 26 	 NP[nb]/N 	 1 	 review a
28 	 27 	 N/N 	 1 	 review substantive
28 	 31 	 (NP\NP)/NP 	 1 	 review on
30 	 25 	 PP/NP 	 1 	 evaluation in
30 	 26 	 NP[nb]/N 	 1 	 evaluation a
30 	 27 	 N/N 	 1 	 evaluation substantive
30 	 31 	 (NP\NP)/NP 	 1 	 evaluation on
33 	 31 	 (NP\NP)/NP 	 2 	 par on
33 	 32 	 NP[nb]/N 	 1 	 par a
33 	 34 	 (NP\NP)/NP 	 1 	 par with
37 	 34 	 (NP\NP)/NP 	 2 	 decision with
37 	 35 	 NP[nb]/N 	 1 	 decision a
37 	 36 	 N/N 	 1 	 decision policy
<\s>
<s id="wsj_0455.27"> 26
1 	 0 	 N/N 	 1 	 Dynamics General
1 	 2 	 (S[dcl]\NP)/PP 	 1 	 Dynamics appealed
1 	 8 	 S[pss]\NP 	 1 	 Dynamics backed <XB>
1 	 15 	 (S[ng]\NP)/S[em] 	 1 	 Dynamics arguing <XB>
3 	 2 	 (S[dcl]\NP)/PP 	 2 	 to appealed
6 	 3 	 PP/NP 	 1 	 court to
6 	 4 	 NP[nb]/N 	 1 	 court the
6 	 5 	 N/N 	 1 	 court high
8 	 9 	 ((S\NP)\(S\NP))/NP 	 2 	 backed by
13 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 groups by
13 	 10 	 N/N 	 1 	 groups numerous
13 	 11 	 N/N 	 1 	 groups business
13 	 12 	 N/N 	 1 	 groups trade
16 	 15 	 (S[ng]\NP)/S[em] 	 2 	 that arguing
20 	 17 	 NP[nb]/N 	 1 	 definition the
20 	 18 	 N/N 	 1 	 definition appeals
20 	 19 	 N/N 	 1 	 definition court
20 	 21 	 (S[dcl]\NP)/NP 	 1 	 definition restricts
21 	 16 	 S[em]/S[dcl] 	 1 	 restricts that
21 	 25 	 (S\NP)\(S\NP) 	 2 	 restricts severely
23 	 21 	 (S[dcl]\NP)/NP 	 2 	 defense restricts
23 	 22 	 NP[nb]/N 	 1 	 defense the
25 	 24 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 severely too
<\s>
<s id="wsj_0455.28"> 25
1 	 0 	 N/N 	 1 	 Dynamics General
1 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 Dynamics was
1 	 3 	 S[pss]\NP 	 1 	 Dynamics sued <XB>
3 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 sued was
3 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 sued by
6 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 families by
6 	 5 	 NP[nb]/N 	 1 	 families the
6 	 7 	 (NP\NP)/NP 	 1 	 families of
10 	 7 	 (NP\NP)/NP 	 2 	 divers of
10 	 8 	 N/N 	 1 	 divers five
10 	 9 	 N/N 	 1 	 divers Navy
10 	 11 	 (NP\NP)/(S[dcl]\NP) 	 1 	 divers who
10 	 12 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 divers were <XB>
10 	 13 	 S[pss]\NP 	 1 	 divers killed <XB>
12 	 11 	 (NP\NP)/(S[dcl]\NP) 	 2 	 were who
13 	 12 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 killed were
13 	 14 	 ((S\NP)\(S\NP))/NP 	 2 	 killed in
13 	 16 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 killed after
15 	 14 	 ((S\NP)\(S\NP))/NP 	 3 	 1982 in
17 	 18 	 (S[dcl]\NP)/NP 	 1 	 they re-entered
18 	 16 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 re-entered after
18 	 21 	 ((S\NP)\(S\NP))/NP 	 2 	 re-entered through
20 	 18 	 (S[dcl]\NP)/NP 	 2 	 submarine re-entered
20 	 19 	 NP[nb]/N 	 1 	 submarine a
24 	 21 	 ((S\NP)\(S\NP))/NP 	 3 	 chamber through
24 	 22 	 NP[nb]/N 	 1 	 chamber a
24 	 23 	 N/N 	 1 	 chamber diving
<\s>
<s id="wsj_0455.29"> 10
1 	 0 	 NP[nb]/N 	 1 	 accident The
1 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 accident was
1 	 3 	 S[pss]\NP 	 1 	 accident caused <XB>
3 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 caused was
3 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 caused by
6 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 operation by
6 	 5 	 N/N 	 1 	 operation faulty
6 	 7 	 (NP\NP)/NP 	 1 	 operation of
9 	 7 	 (NP\NP)/NP 	 2 	 valve of
9 	 8 	 NP[nb]/N 	 1 	 valve a
<\s>
<s id="wsj_0455.30"> 16
3 	 0 	 NP[nb]/N 	 1 	 court A
3 	 1 	 N/N 	 1 	 court federal
3 	 2 	 N/N 	 1 	 court district
3 	 4 	 ((S[dcl]\NP)/PP)/NP 	 1 	 court awarded
5 	 4 	 ((S[dcl]\NP)/PP)/NP 	 3 	 damages awarded
6 	 4 	 ((S[dcl]\NP)/PP)/NP 	 2 	 to awarded
8 	 6 	 PP/NP 	 1 	 families to
8 	 7 	 NP[nb]/N 	 1 	 families the
12 	 10 	 NP[nb]/N 	 1 	 court the
12 	 11 	 N/N 	 1 	 court appeals
12 	 13 	 (S[dcl]\NP)/NP 	 1 	 court affirmed
15 	 13 	 (S[dcl]\NP)/NP 	 2 	 award affirmed
15 	 14 	 NP[nb]/N 	 1 	 award the
<\s>
<s id="wsj_0455.31"> 5
3 	 1 	 N/N 	 1 	 Corp. General
3 	 2 	 N/N 	 1 	 Corp. Dynamics
3 	 4 	 (NP\NP)/NP 	 1 	 Corp. vs.
5 	 4 	 (NP\NP)/NP 	 2 	 Trevino vs.
<\s>
<s id="wsj_0455.32"> 2
0 	 1 	 (NP\NP)/NP 	 1 	 Court in
2 	 1 	 (NP\NP)/NP 	 2 	 Brief in
<\s>
<s id="wsj_0455.33"> 8
0 	 3 	 PP\PP 	 1 	 In yesterday
2 	 0 	 (PP/NP)/NP 	 2 	 action In
2 	 1 	 N/N 	 1 	 action other
7 	 0 	 (PP/NP)/NP 	 1 	 court In
7 	 5 	 NP[nb]/N 	 1 	 court the
7 	 6 	 N/N 	 1 	 court high
<\s>
<s id="wsj_0455.34"> 27
2 	 1 	 (S[dcl]\NP)/S[b] 	 2 	 stand Let
5 	 2 	 S[b]/NP 	 1 	 fraud stand
5 	 3 	 NP[nb]/N 	 1 	 fraud the
5 	 4 	 N/N 	 1 	 fraud mail
5 	 9 	 (NP\NP)/NP 	 1 	 fraud of
8 	 2 	 S[b]/NP 	 1 	 conviction stand
8 	 3 	 NP[nb]/N 	 1 	 conviction the
8 	 4 	 N/N 	 1 	 conviction mail
8 	 7 	 N/N 	 1 	 conviction conspiracy
8 	 9 	 (NP\NP)/NP 	 1 	 conviction of
11 	 9 	 (NP\NP)/NP 	 2 	 Lavery of
11 	 10 	 N/N 	 1 	 Lavery John
16 	 9 	 (NP\NP)/NP 	 2 	 president of
16 	 13 	 NP[nb]/N 	 1 	 president a
16 	 14 	 N/N 	 1 	 president former
16 	 15 	 N/N 	 1 	 president vice
16 	 17 	 (NP\NP)/NP 	 1 	 president of
20 	 17 	 (NP\NP)/NP 	 2 	 Corp. of
20 	 18 	 N/N 	 1 	 Corp. Beech-Nut
20 	 19 	 N/N 	 1 	 Corp. Nutrition
23 	 17 	 (NP\NP)/NP 	 2 	 unit of
23 	 22 	 NP[nb]/N 	 1 	 unit a
23 	 24 	 (NP\NP)/NP 	 1 	 unit of
26 	 24 	 (NP\NP)/NP 	 2 	 S.A of
26 	 25 	 N/N 	 1 	 S.A Nestle
<\s>
<s id="wsj_0455.35"> 20
1 	 0 	 NP[nb]/N 	 1 	 conviction The
1 	 2 	 (S[dcl]\NP)/PP 	 1 	 conviction stemmed
3 	 2 	 (S[dcl]\NP)/PP 	 2 	 from stemmed
5 	 3 	 PP/NP 	 1 	 charges from
5 	 4 	 N/N 	 1 	 charges federal
5 	 6 	 (NP\NP)/NP 	 1 	 charges of
5 	 9 	 (NP\NP)/NP 	 1 	 charges for
8 	 6 	 (NP\NP)/NP 	 2 	 fraud of
8 	 7 	 N/N 	 1 	 fraud consumer
10 	 9 	 (NP\NP)/NP 	 2 	 sale for
10 	 11 	 (NP\NP)/NP 	 1 	 sale of
10 	 16 	 (NP\NP)/NP 	 1 	 sale between
15 	 11 	 (NP\NP)/NP 	 2 	 juice of
15 	 12 	 N/N 	 1 	 juice phony
15 	 13 	 N/N 	 1 	 juice infant
15 	 14 	 N/N 	 1 	 juice apple
17 	 16 	 (NP\NP)/NP 	 2 	 1978 between
19 	 16 	 (NP\NP)/NP 	 2 	 1983 between
<\s>
<s id="wsj_0455.36"> 5
1 	 2 	 (NP\NP)/NP 	 1 	 Lavery vs.
3 	 2 	 (NP\NP)/NP 	 2 	 U.S. vs.
<\s>
<s id="wsj_0455.37"> 27
2 	 1 	 ((S[dcl]\NP)/NP)/(S[adj]\NP) 	 3 	 intact Left
4 	 1 	 ((S[dcl]\NP)/NP)/(S[adj]\NP) 	 2 	 award Left
4 	 2 	 S[adj]\NP 	 1 	 award intact <XB>
4 	 3 	 NP[nb]/N 	 1 	 award an
4 	 5 	 (NP\NP)/NP 	 1 	 award of
4 	 11 	 (NP\NP)/NP 	 1 	 award against
4 	 15 	 (NP\NP)/NP 	 1 	 award in
6 	 5 	 (NP\NP)/NP 	 2 	 $ of
6 	 9 	 (NP\NP)/NP 	 1 	 $ in
8 	 6 	 N/N[num] 	 1 	 million $
8 	 7 	 N/N 	 1 	 million 1.5
10 	 9 	 (NP\NP)/NP 	 2 	 damages in
14 	 11 	 (NP\NP)/NP 	 2 	 Co. against
14 	 12 	 N/N 	 1 	 Co. Dow
14 	 13 	 N/N 	 1 	 Co. Chemical
17 	 15 	 (NP\NP)/NP 	 2 	 death in
17 	 16 	 NP[nb]/N 	 1 	 death the
17 	 18 	 (NP\NP)/NP 	 1 	 death of
17 	 22 	 (NP\NP)/NP 	 1 	 death from
21 	 18 	 (NP\NP)/NP 	 2 	 man of
21 	 19 	 NP[nb]/N 	 1 	 man an
21 	 20 	 N/N 	 1 	 man Oregon
23 	 22 	 (NP\NP)/NP 	 2 	 exposure from
23 	 24 	 (NP\NP)/NP 	 1 	 exposure to
26 	 24 	 (NP\NP)/NP 	 2 	 Orange to
26 	 25 	 N/N 	 1 	 Orange Agent
<\s>
<s id="wsj_0455.38"> 32
1 	 0 	 NP[nb]/N 	 1 	 award The
1 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 award was
1 	 3 	 (S[pss]\NP)/PP 	 1 	 award made <XB>
3 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 made was
3 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 made by
7 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 court by
7 	 5 	 NP[nb]/N 	 1 	 court a
7 	 6 	 N/N 	 1 	 court federal
8 	 3 	 (S[pss]\NP)/PP 	 2 	 to made
10 	 8 	 PP/NP 	 1 	 widow to
10 	 9 	 NP[nb]/N 	 1 	 widow the
10 	 11 	 (NP\NP)/NP 	 1 	 widow of
16 	 11 	 (NP\NP)/NP 	 2 	 employee of
16 	 12 	 NP[nb]/N 	 1 	 employee a
16 	 13 	 N/N 	 1 	 employee U.S.
16 	 14 	 N/N 	 1 	 employee Forest
16 	 15 	 N/N 	 1 	 employee Service
16 	 17 	 (NP\NP)/(S[dcl]\NP) 	 1 	 employee who
16 	 18 	 (S[dcl]\NP)/NP 	 1 	 employee contracted <XB>
16 	 23 	 (S[ng]\NP)/NP 	 1 	 employee using <XB>
18 	 17 	 (NP\NP)/(S[dcl]\NP) 	 2 	 contracted who
18 	 22 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 2 	 contracted after
19 	 20 	 (NP[nb]/N)\NP 	 2 	 Hodgkin 's
21 	 18 	 (S[dcl]\NP)/NP 	 2 	 disease contracted
21 	 20 	 (NP[nb]/N)\NP 	 1 	 disease 's
23 	 22 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 using after
23 	 28 	 ((S\NP)\(S\NP))/NP 	 2 	 using in
24 	 23 	 (S[ng]\NP)/NP 	 2 	 herbicides using
24 	 25 	 (S[ng]\NP)/NP 	 1 	 herbicides containing <XB>
27 	 25 	 (S[ng]\NP)/NP 	 2 	 Orange containing
27 	 26 	 N/N 	 1 	 Orange Agent
31 	 28 	 ((S\NP)\(S\NP))/NP 	 3 	 program in
31 	 29 	 NP[nb]/N 	 1 	 program a
31 	 30 	 N/N 	 1 	 program weed-killing
<\s>
